Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Sanofi

Clinicaltrial registered27 Oct 2026

Sanofi

27 Oct 2026: Trial registered · A Study to Describe Multiple Sclerosis Patients Treated With Tolebrutinib as Per Label in a Real-world Setting. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
27 Oct 2026
Title
A Study to Describe Multiple Sclerosis Patients Treated With Tolebrutinib as Per Label in a Real-world Setting
Conditions
Multiple Sclerosis
Study Type
Observational
Status
Recruiting
Countries
United Arab Emirates
Country
United Arab Emirates
Reference
NCT07898371
Location
United Arab Emirates
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Sanofi

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

Across AOS Research

Other records for Sanofi in our registers.

More from United Arab Emirates

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.